AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2016

Aug 9, 2016

30198_dirs_2016-08-09_b117b88c-7b5c-4835-8f0b-a858ccd7b4ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-08-08

Reporting Person: Pacelli Steven Robert (EVP, Strategy & Corp. Dev.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-08	Common Stock	M	4.0	$11.33	Acquired	161922	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-08	Incentive Stock Option (right to buy)	$11.33	M	4.0	Disposed	2016-08-08	Common Stock (4)	Direct

Footnotes

F1: Included in this number are 91,667 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 30,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 23,667 of which were granted on March 8, 2014 and shall vest through March 8, 2017.